164 related articles for article (PubMed ID: 16504213)
21. Effects of different inspired oxygen fractions on sildenafil-induced pulmonary anti-hypertensive effects in a sheep model of acute pulmonary embolism.
Velásquez DR; Teixeira-Neto FJ; Paola Lagos-Carvajal A; Steim-Diniz M; Rodríguez NC; Dias-Junior CA
Life Sci; 2015 Apr; 127():26-31. PubMed ID: 25744408
[TBL] [Abstract][Full Text] [Related]
22. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
[TBL] [Abstract][Full Text] [Related]
23. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
24. [Sildenafil reduces pressure and pulmonary resistance and increases susceptibility of pulmonary arteries to nitric oxide in primary pulmonary arterial hypertension].
Wodniecki J; Jacheć W; Poloński L; Tomasik AR; Wojciechowska C; Foremny A
Przegl Lek; 2005; 62(2):135-8. PubMed ID: 16095162
[TBL] [Abstract][Full Text] [Related]
25. Acute hemodynamic effects of sildenafil in patients with idiopathic dilated cardiomyopathy.
Ramakrishnan S; Malik V; Karthikeyan G; Seth S; Yadav R; Singh S; Deepak KK; Bhargava B
Indian Heart J; 2008; 60(6):599-601. PubMed ID: 19276506
[TBL] [Abstract][Full Text] [Related]
26. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism.
Fortuna GM; Figueiredo-Lopes L; Dias-Junior CA; Gerlach RF; Tanus-Santos JE
Int J Cardiol; 2007 Jan; 114(1):22-7. PubMed ID: 16650492
[TBL] [Abstract][Full Text] [Related]
27. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats.
Itoh T; Nagaya N; Fujii T; Iwase T; Nakanishi N; Hamada K; Kangawa K; Kimura H
Am J Respir Crit Care Med; 2004 Jan; 169(1):34-8. PubMed ID: 14525801
[TBL] [Abstract][Full Text] [Related]
28. Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism.
Dias-Junior CA; Sertorio JT; Tanus-Santos JE
Acta Physiol (Oxf); 2007 Nov; 191(3):189-96. PubMed ID: 17784902
[TBL] [Abstract][Full Text] [Related]
29. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
[TBL] [Abstract][Full Text] [Related]
30. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
Lee JE; Hillier SC; Knoderer CA
J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
[TBL] [Abstract][Full Text] [Related]
31. No adverse hemodynamic interaction between sildenafil and red wine.
Leslie SJ; Atkins G; Oliver JJ; Webb DJ
Clin Pharmacol Ther; 2004 Oct; 76(4):365-70. PubMed ID: 15470336
[TBL] [Abstract][Full Text] [Related]
32. The effects of tamsulosin and sildenafil in separate and combined regimens on detailed hemodynamics in patients with benign prostatic enlargement.
Nieminen T; Tammela TL; Kööbi T; Kähönen M
J Urol; 2006 Dec; 176(6 Pt 1):2551-6. PubMed ID: 17085157
[TBL] [Abstract][Full Text] [Related]
33. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M
Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
[TBL] [Abstract][Full Text] [Related]
34. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ
J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539
[TBL] [Abstract][Full Text] [Related]
35. Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection.
Jamnicki-Abegg M; Weihrauch D; Chiari PC; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
J Cardiovasc Pharmacol; 2007 Dec; 50(6):670-6. PubMed ID: 18091584
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of inhaled and intravenous sildenafil in the prevention of the pulmonary endothelial dysfunction due to cardiopulmonary bypass.
Aubin MC; Laurendeau S; Mommerot A; Lamarche Y; Denault A; Carrier M; Perrault LP
J Cardiovasc Pharmacol; 2008 Jan; 51(1):11-7. PubMed ID: 18209563
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
Noori S; Friedlich P; Wong P; Garingo A; Seri I
Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
[TBL] [Abstract][Full Text] [Related]
38. Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
Zhao G; Messina E; Xu X; Ochoa M; Serpillon S; Shryock J; Belardinelli L; Hintze TH
Eur J Pharmacol; 2006 Jul; 541(3):171-6. PubMed ID: 16777088
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide modulates air embolism-induced lung injury in rats with normotension and hypertension.
Liu YC; Kao SJ; Chuang IC; Chen HI
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1173-80. PubMed ID: 17880373
[TBL] [Abstract][Full Text] [Related]
40. Long-term effects of early administered sildenafil and NO donor on the cardiovascular system of SHR.
Kristek F; Koprdová R; Cebová M
J Physiol Pharmacol; 2007 Mar; 58(1):33-43. PubMed ID: 17440224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
